10x Genomics, Inc.
TXG
$22.37
-$0.25-1.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 76.16% | 58.19% | 64.72% | 40.58% | 28.41% |
| Total Depreciation and Amortization | 0.25% | -5.73% | -10.42% | -9.61% | 0.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.20% | -25.19% | -23.87% | -21.89% | -19.34% |
| Change in Net Operating Assets | 1,888.76% | -74.69% | -160.30% | 110.70% | -92.77% |
| Cash from Operations | 1,941.57% | 126.00% | 961.12% | 311.74% | 143.85% |
| Capital Expenditure | 52.11% | 47.63% | 58.83% | 75.77% | 74.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 108.72% | -205.64% | -173.74% | -147.50% | -111.11% |
| Cash from Investing | 58.82% | -297.21% | -243.04% | -286.84% | -124.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -37.67% | -24.41% | -46.90% | -48.20% | -43.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -37.67% | -24.41% | -46.90% | -48.20% | -20.16% |
| Foreign Exchange rate Adjustments | 395.12% | -5.49% | 711.86% | 98.10% | -396.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 953.64% | -58.58% | -63.47% | 33.11% | -111.53% |